"This new alliance with Philips integrates cutting-edge technology, healthcare excellence, innovation, and research, which are the fundamental pillars on which we support our commitment to always seek the best experience for our patients, said, Dr. Pedro Rico, CEO of Vithas Group.
“At Philips we are leading digital transformation in healthcare, with a portfolio that includes solutions for both professionals and consumers to support parents-to-be through pregnancy and the first years of their baby’s life,” said Jeroen Tas, Chief Innovation & Strategy Officer, Royal Philips.
Building on its strong portfolio to support oncology clinical decision-making, the company brings together the power of imaging, pathology, genomics, and longitudinal data with insights from artificial intelligence, to empower clinicians to deliver clear care pathways with predictable outcomes for every patient.
As a multimodality (MR and CT), vendor-neutral digital hub, the Radiology Operations Command Center connects imaging experts at a central command center with technologists and onsite staff in locations across an entire enterprise for real-time, over-the-shoulder collaboration and support.
“To unleash the power of younger healthcare professionals, the U.S. must invest in advanced systems of engagement beyond the EMR that fit into the physician’s workflow as well as data sharing tools and technologies that can help them treat patients and reduce stress. This will help to improve the work-life balance for American healthcare professionals,” said Dr. Joseph Frassica, chief medical officer and head of research for Philips North America. “We also need to focus on tools to help with administrative and business management processes and then give these professionals the autonomy they need to focus on what is most important to them – delivering exceptional patient care.”
Royal Philips reports the findings reveal how the COVID-19 pandemic has affected the attitudes and experiences of younger doctors, and how they believe the healthcare industry should change in response.
The new wire supports iFR (instant wave-Free Ratio) measurements, the only resting index supported by randomized controlled outcome trials [1-3], as well as FFR (fractional flow reserve) measurements. It also integrates with the Philips IntraSight interventional applications platform, which can co-register iFR data onto the angiogram (interventional X-ray image) to precisely identify the parts of vessels requiring treatment.